investorscraft@gmail.com

Stock Analysis & ValuationPRF Technologies Ltd. (PRFX)

Previous Close
$1.89
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

65 Yigal Alon Street
Tel Aviv 6745442
IL
Phone: 972 3 717 7050
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: Ehud Geller
Full Time Employees: 2

PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

HomeMenuAccount